More new products in the pipeline for 2020

 

Asaleo Care has reported a three per cent revenue growth to $420 million for the full year 2019, with its B2B division performing strongly in the healthcare and aged care sectors.

 

The B2B segment delivered strong revenue growth of 2.8 per cent in the second half, primarily due to increased sales of high margin, proprietary systems in its professional hygiene business. 

 

Full year B2B revenue growth was up 1.6 per cent to $221.6 million. However, profit margins were adversely impacted by high input costs such as energy and insurance, as well as investment in incremental sales resources to drive future growth. 

 

For the year, sales of Tork professional hygiene products increased one per cent while sales of TENA incontinence products in the healthcare sector increased by three per cent due to underlying growth in demand from the residential aged care and in-home care sectors.

 

Sid Takla, Asaleo Care CEO, said: “The business has returned to revenue growth, which was achieved across both our business segments: Retail and B2B. 

 

 “With the completion of the sale of the Australian consumer tissue business during the year, we have reduced our debt and strengthened our balance sheet for future growth. In 2020, we will build on this momentum to launch more new products, continue to invest in our brands, leverage our new equipment investment at Kawerau, NZ and deliver on our new contract wins, including the contract with the Victorian Government,” he said. 

 

Asaleo Care’s brands includes Libra, TENA, Tork, Treasures, Viti and Orchid. The Purex, Sorbent, Handee Ultra and Deeko brands are not owned in Australia.